Altoida Inc. is a health technology firm that uses active digital biomarkers and cutting-edge technology in Artificial Intelligence (AI) and Augmented Reality (AR) to classify patients' risk of Mild Cognitive Impairment (MCI) due to Alzheimer's Disease (AD) and drive better clinical outcomes for brain diseases.
Market
Alzheimer's Disease and Cognitive Health
Location
Houston,
Texas,
USA
Coinvestors
Alpana Ventures, btov Partners, FYRFLY Venture Partners, Hikma Ventures, HonorHealth, M Ventures, VI Partners, Whitecap Venture Partners